Russia’s covid vaccine may reach Kanpur next week for phase 2, 3 trials


    Russia s covid vaccine may reach Kanpur next week for stage 2, 3 trials

    By: PTI|Kanpur |

    Updated: November 15, 2020 2: 33: 11 pm

    Coronavirus vaccine, Sputnik V, Covid-19, Russian Covid vaccine, Russia coronavirus, Covid cases, MERS virus, Middle East Respiratory syndrome, Indian express opinion A view of a vial of Russia’s experimental Sputnik V coronavirus vaccine. (Picture: AP)

    The first batch of Russia s Sputnik V vaccine for COVID-19 is likely to reach Kanpur s Ganesh Shankar Vidyarthi Medical College by next week where the vaccine s Stage 2 and Phase 3 human medical trials will be performed.

    The choice to carry out the human clinical trials of the vaccine was taken after Dr Reddy s Laboratories got approval from the Drugs Controller General of India (DCGI) in this regard, an official stated.

    Speaking to PTI, college principal R B Kamal stated the human scientific trials of the vaccine will begin with next week.

    As numerous as 180 volunteers have actually registered for the trials. Head of the research Saurabh Agarwal will figure out the dosage of the vaccine to be administered. One dosage will be administered and the condition of volunteers will be monitored to figure out whether they require additional dosages or not, he said.

    READ | Discussed: Moderna vaccine interim trial results most likely next week, what is the status of other shots?

    Kamal said the volunteers vitals and condition will be examined occasionally and the data will be evaluated to identify whether the vaccine is a success or not.

    He said the impact of the vaccine on the volunteers will be studied for seven months after the same is administered as soon as, two times or thrice within an interval of 21 days.

    After observing the impacts of the vaccine for a month, authorities will be apprised of the results of the trial and they will then decide accordingly.

    The Ethics Committee of the college has actually also permitted for the tracks, he said.

    The vaccine needs to be kept at a temperature level of -20 to -70 degrees Celsius.

    In September, Dr Reddy s and the Russian Direct Mutual Fund (RDIF), Russia s sovereign wealth fund, participated in a collaboration to perform clinical trials of Sputnik V vaccine and its distribution in India.

    As part of the collaboration, RDIF shall provide 100 million dosages of the vaccine to Dr Reddy s upon regulatory approval in India.

    On August 11, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the world s first signed up vaccine versus COVID-19 based on the human adenoviral vector platform.

    The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay upgraded with the newest headings

    For all the most recent India News, download Indian Express App.

    ( the headline, this story has actually not been released by Important India News staff and is published from a syndicated feed.).


    Please enter your comment!
    Please enter your name here